Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Keywords: APOPTOSIS ; CANCER ; CANCER CELLS ; CELLS ; EXPRESSION ; GROWTH ; IN-VITRO ; SURVIVAL ; carcinoma ; CELL ; Germany ; IN-VIVO ; INHIBITION ; THERAPY ; VITRO ; VIVO ; DENSITY ; GENE ; GENES ; PROTEIN ; TISSUE ; LINES ; MICE ; PATIENT ; IMPACT ; INDUCTION ; CELL-LINES ; treatment ; BREAST-CANCER ; prevention ; resistance ; PLASMA ; ovarian cancer ; OVARIAN-CANCER ; NUDE-MICE ; CELL-LINE ; chemotherapy ; LINE ; CANCER-CELLS ; CANCER-PATIENTS ; CARCINOMAS ; ovarian carcinoma ; CANCER PATIENTS ; cell lines ; CANCER-THERAPY ; protein expression ; ONCOLOGY ; RE ; TUMOR-GROWTH ; cancer therapy ; EX-VIVO ; LEVEL ; PLASMA-LEVELS ; dexamethasone ; NAUSEA ; OVARIAN CARCINOMAS ; corticosteroids ; GLUCOCORTICOIDS ; in vivo ; OVARIAN ; viability ; xenograft
    Abstract: The glucocorticoid dexamethasone is frequently used as a co-treatment in cytotoxic cancer therapy, e.g. to prevent nausea, to protect normal tissue or for other reasons. While the potent pro-apoptotic properties and supportive effects of glucocorticoids to tumour therapy in lymphoid cells are well studied, the impact on the cytotoxic treatment of ovarian carcinoma is unknown. We tested apoptosis-induction, viability, tumour growth and protein expression using established cell lines, primary cell lines freshly isolated from patient material and a xenograft on nude mice. We found a general induction of resistance toward cytotoxic therapy by DEX-co-treatment in most of the examined ovarian cancer cells treated in vitro, ex vivo or in vivo. Resistance occured independently of cell density and was found at peak plasma levels of dexamethasone and below. Mechanistically, the dexamethasone-induced expression of survival genes may be involved in the resistance. These data show that glucocorticoid-induced resistance is common in ovarian carcinomas implicating that the use of glucocorticoids may be harmful for cancer patients
    Type of Publication: Journal article published
    PubMed ID: 16391812
    Signatur Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...